Why CVS fell on Nov 4
Down 13% on Nov 4, and still 7% under its Nov 3 close.
- Its Nov 4 results:
CVS's Quality Score rose 1 point on Mon, Nov 9, to 14. Buying reached its highest in 20 days (2 chart checks started).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 13% on Nov 4, and still 7% under its Nov 3 close.
| The company | Profit up 2,253% to $11.0B |
| Latest filing | 8-K, Nov 4 |
InsiderDisclosed Fri Nov 6: Shah Prem S, President, bought $2M on Nov 6. Form 4
CVS Health to split into two publicly traded companies by 2028, FT reports
A results day: the move is left out.
After its last 4 reports it closed -2.5% on average, higher 1 of 4 times.
CVS is #87 of 552 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 87 |
Expected to report Tue Feb 9, before the open (in 91 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $108.4B, 5% more than a year ago; a profit of $1.68 a share, from a loss of $3.13.
“Total revenues increased 5.4% primarily driven by growth in the Health Services and Health Care Benefits segments.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Product | $69B | $66B | $65B |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 4)
| Measure | Figure |
|---|---|
| GAAP diluted EPS | at least $6.98 |
“Adjusted EPS of $2.09 increased from $1.60 in the prior year, primarily due to improved adjusted operating income in the Health Care Benefits segment, reflecting continued execution of its margin recovery plan.”
From its results filing (SEC filing · Nov 4)
Sales grew 8.4% a year over 5 years, fiscal 2020 to 2025.
Pays $2.66 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 4, 2026 | -6.7% | -12.5% | not yet |
| Aug 5, 2026 | -10.3% | -5.1% | -10.5% |
| May 6, 2026 | +6.0% | +7.7% | +17.9% |
Sales grew every year from 2018 to 2025, to $402B. It made a profit in seven of the eight years.
RSI 44.9, MACD below signal, below both averages. Not scored.
Its dividends come to 22% of its free cash flow.
| Dividend | $2.66 a share a year |
| Paid out | About $3.4B a year |
| Free cash flow | $16B |
One insider bought $2M across 1 filing, and one insider sold $317M across 7 filings, in the last 6 months. The newest:
14 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: CVS is 0.4% of VYM, 0.2% of JEPI, and 0.2% of VOO, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026.
CVS Health currently offers a diverse set of healthcare services, although it plans to split into two organizations in early 2028. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix.
“The health care benefits industry is highly competitive, primarily due to a large number of for-profit and not-for-profit competitors, competitors’ marketing and pricing and a proliferation of competing products, including new products that are continually being introduced into the marketplace.”
CVS scores 14 today, which Breakaway calls Above Average. It is #87 of 552 in Healthcare by Quality Score, with 4 of 14 chart checks firing. Down 13% on Nov 4, and still 7% under its Nov 3 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
CVS scores 14 today, which Breakaway calls Above Average (11 to 14). That is #87 of 552 in Healthcare by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CVS's 14.
One insider bought $2M across 1 filing, and one insider sold $317M across 7 filings, in the last 6 months. The newest is Prem S. Shah, EVP and Group President, who bought $2M on Nov 6. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free for 24 hours. No account. No card. Then keep going with a free account.